Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...
Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...
Following the Thursday confirmation of Robert F. Kennedy Jr. as head of Health and Human Services, doctors weigh in on the new secretary’s plans to make America healthy again.
In this process, royalty recipients often face the issue where multiple small future royalty streams cannot fulfill ongoing large lump-sum R&D funding needs. The mismatch is where Royalty Pharma ...
California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But ...
Health scientists and drug industry executives around the world are on alert after the confirmation of Robert F. Kennedy Jr., who spreads antivaccine misinformation and has often derided the ...
Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...
For context, tech giants still top the global wealth charts. Elon Musk is by far the richest man in the world, with a total ...
Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...
Trump’s tariffs on products from the EU and TK add to a big trade bill that will hit U.S. states, with Texas and California ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Corbus Pharmaceuticals (CRBP – Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results